IndiaInfoline » Markets » AUROPHARMA

Aurobindo Pharma Ltd - Share Price

AUROPHARMA

Open

448.10

Prev. Close

449.25

Turnover (lac.)

9,734

Day's High

451.50

Day's Low

444.00

52 Week's High

838.00

52 Week's Low

389.35

Book Value

206

Face Value

1

Mkt Cap (Cr.)

26,294

P/E

15.91

EPS

28.2

Divi. Yield

0.56

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd434.1539.80104,083.15823.160.633,215.0198.33
Divis Laboratories Ltd1,829.1537.6848,575.44352.830.871,403.92266.77
Dr Reddys Laboratories Ltd2,905.6519.1948,278.181,365.100.693,435.30852.70
Cipla Ltd461.0515.7337,134.73737.380.653,230.08209.72
Biocon Ltd292.85118.1535,160.00106.100.17523.9059.29

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulation... More

Registered Office

Plot No 2 Maitrivihar,Behind Maithri Vanam Ameerpet,Hyderabad, Telangana,500038

Tell. : +91-40-23736370
Website : http://www.aurobindo.com
Email : info@aurobindo.com/investorgrievances@aurobindo.co

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by Aurobindo-Pharma-Ltd

View

- <

Reco. Price

Nov 29,2019 09:24 AM

Target Price

Target Returns:

0.00%

Result Express

Aurobindo Pharma Ltd's Q3FY19 consolidated net profit rises 19.7% yoy to Rs712.22cr : Beats Estimates

Dec 12, 2019 09:29 PM

The company’s consolidated revenue stood at Rs5,269.67cr, up 21.53% yoy and 10.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    EGM

    Exp. Date

    30 Nov 2019

    Annc. Date

    25 Oct 2019

    COM 30/11/2019Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Re... More

  • Purpose

    Dividend

    Annc. Date

    12 Nov 2019

    Effective. Date

    21 Nov 2019

    Divi. Type

    Interim

    Divi.(%)

    125

    Divi. Amt.

    1.25

    The Board of Directors of the Company at its meeting held today,November 12,2019,has interalia, tran... More

  • Purpose

    Board Meeting

    Exp. Date

    12 Nov 2019

    Annc. Date

    31 Oct 2019

    AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is s... More